For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategically positioned to capitalize on this market shift. The departure of Chinese players from the market opens a significant gap, which Indian companies are well-equipped to fill .
Navratnas of the market: 9 investing mantras from Devina Mehra’s new book
Investment mantras aren’t morning chants you recite with closed eyes and crossed legs. “They are what you believe are at the foundation of your whole
April 14, 2025